- Response: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)
-
Sicras-Mainar A, Navarro-Artieda R
- KMID: 1805902
- Diabetes Metab J.
- 2015 Apr;39(2):173-174.
- doi: 10.4093/dmj.2015.39.2.173
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients
-
Sicras-Mainar A, Navarro-Artieda R
- KMID: 2280660
- Diabetes Metab J.
- 2015 Feb;39(1):74-81.
- doi: 10.4093/dmj.2015.39.1.74
BACKGROUND: To evaluate resource use and health costs due to the combination of metformin and dipeptidyl peptidase-4 (DPP-4) inhibitors in patients with diabetes and renal impairment in routine clinical practice. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
